Recent Publications

Bitte geben Sie einen Suchbegriff ein.

van Schaik IN, Mielke O; PATH study group.

Intravenous versus subcutaneous immunoglobulin - Authors' reply.

Lancet Neurol. 2018 May;17(5):393-394. doi: 10.1016/S1474-4422(18)30109-1. PubMed ID: 29656738

 

Further Information:

undefinedPubMed

undefinedHans-Peter Hartung


Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators.

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12. PubMed ID: 29545067

 

Further Information:

undefinedPubMed

undefinedHans-Peter Hartung


Wirsching HG, Tabatabai G, Roelcke U, Hottinger AF, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Caparrotti F, von Moos R, Riklin C, Felsberg J, Roth P, Jones DTW, Pfister S, Rushing EJ, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, Weller M.

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.

Ann Oncol. 2018 Apr 10. doi: 10.1093/annonc/mdy120. [Epub ahead of print] PubMed ID: 29648580

 

Further Information:

undefinedPubMed

undefinedGuido Reifenberger


González de San Román E, Bidmon HJ, Malisic M, Susnea I, Küppers A, Hübbers R, Wree A, Nischwitz V, Amunts K, Huesgen PF.

Molecular composition of the human primary visual cortex profiled by multimodal mass spectrometry imaging.

Brain Struct Funct. 2018 Apr 10. doi: 10.1007/s00429-018-1660-y. [Epub ahead of print] PubMed ID: 29633039

 

Further Information:

undefinedPubMed

undefinedKatrin Amunts


Kedo O, Zilles K, Palomero-Gallagher N, Schleicher A, Mohlberg H, Bludau S, Amunts K.

Receptor-driven, multimodal mapping of the human amygdala.

Brain Struct Funct. 2018 May;223(4):1637-1666. doi: 10.1007/s00429-017-1577-x. Epub 2017 Nov 29. PubMed ID: 29188378

 

Further Information:

undefinedPubMed

undefinedKatrin Amunts


Küry P, Nath A, Créange A, Dolei A, Marche P, Gold J, Giovannoni G, Hartung HP, Perron H.

Human Endogenous Retroviruses in Neurological Diseases.

Trends Mol Med. 2018 Apr;24(4):379-394. doi: 10.1016/j.molmed.2018.02.007. Epub 2018 Mar 15. PubMed ID: 29551251

 

Further Information:

undefinedPubMed

undefinedPatrick Küry

undefinedHans-Peter Hartung


Owen MC, Kulig W, Poojari C, Rog T, Strodel B.

Physiologically-relevant levels of sphingomyelin, but not GM1, induces a β-sheet-rich structure in the amyloid-β(1-42) monomer.

Biochim Biophys Acta. 2018 Apr 4. pii: S0005-2736(18)30106-8. doi: 10.1016/j.bbamem.2018.03.026. [Epub ahead of print] PubMed ID: 29626441

 

Further Information:

undefinedPubMed

undefinedBirgit Strodel


Kremer D, Küry P, Hartung HP.

ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosis.

Mult Scler. 2018 Apr 1:1352458518768770. doi: 10.1177/1352458518768770. [Epub ahead of print] PubMed ID: 29629605

 

Further Information:

undefinedPubMed

undefinedPatrick Küry

undefinedHans-Peter Hartung


Genon S, Reid A, Langner R, Amunts K, Eickhoff SB.

How to Characterize the Function of a Brain Region.

Trends Cogn Sci. 2018 Apr;22(4):350-364. doi: 10.1016/j.tics.2018.01.010. Epub 2018 Feb 28. PubMed ID: 29501326

 

Further Information:

undefinedPubMed

undefinedSimon B. Eickhoff


Aktas O.

Shifting borders, crossing boundaries: The case of combined central and peripheral demyelination.

Mult Scler. 2018 Apr;24(4):550-551. doi: 10.1177/1352458517726386. Epub 2017 Aug 10. PubMed ID:28795614

 

Further Information:

undefinedPubMed

undefinedOrhan Aktas


Treffer 1 bis 10 von 69

Verantwortlich für den Inhalt: E-Mail sendenNeuroscience Network Düsseldorf